Welcome to our dedicated page for Genworth Finl SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Genworth Financial, Inc. filings document formal earnings disclosures for an insurance holding company with Enact mortgage insurance operations and a Closed Block of long-term care insurance, life insurance and annuity products. Recent Form 8-K reports furnish quarterly results press releases and financial supplements under Item 2.02.
The filings also record Genworth’s references to Enact Holdings as a publicly traded subsidiary, segment-level reporting context, conference-call notices and exhibit-based financial materials. These disclosures connect reported results to mortgage insurance performance, legacy insurance liabilities, investment impacts and holding-company capital actions.
GENWORTH FINANCIAL INC director Howard D. Mills III received an equity grant of 18,264 shares of Common Stock as part of his annual retainer. The grant reflects restricted stock units (RSUs) that were valued using a twenty-day average trading price of $9.0345 per share.
The RSUs vest on the one-year anniversary of the grant date and convert into shares of Common Stock at vesting, unless Mills elects to defer receipt until his board service ends or to a future specified year. Following this grant, he holds 92,655.011 shares directly.
GENWORTH FINANCIAL INC director Melina E. Higgins received an equity grant as part of her board compensation. She was awarded 31,547 restricted stock units of Common Stock at a reference price of $9.0345 per share, based on the twenty-day average trading price.
The RSUs were granted in payment of a portion of her annual retainer fee. They vest on the one-year anniversary of the grant date and then convert into shares of Common Stock, unless she has elected to defer receipt until leaving the board or a future specified year. After this grant, her direct holdings total 163,728.537 shares of Common Stock.
GENWORTH FINANCIAL INC director Jill R. Goodman received an equity grant of 18,264 shares of Common Stock via restricted stock units. The RSUs were granted as part of her annual retainer fee at an implied price of $9.0345 per share, based on the twenty-day average trading price. These RSUs vest on the one-year anniversary of the grant date and convert into common shares upon vesting, unless she has elected to defer receipt. After this award, Goodman directly holds a total of 92,655.011 shares of Genworth common stock.
Genworth Financial director Karen Elizabeth Dyson received an equity grant as part of her board compensation. She was awarded 18,264 shares of Common Stock in the form of restricted stock units, valued using a twenty-day average trading price of $9.0345 per share.
The RSUs were granted as payment for a portion of her annual retainer fee and will vest on the one-year anniversary of the grant date. Upon vesting, they convert into shares of Common Stock, unless she has elected to defer receipt until leaving the board or to a future year. After this award, she directly holds 92,655.011 shares.
GENWORTH FINANCIAL INC director Conrad G. Kent received an equity compensation grant rather than making an open-market trade. He was awarded 18,264 restricted stock units (RSUs) as part of his annual retainer fee, valued using a $9.0345 twenty-day average trading price per share of Common Stock.
The RSUs vest on the one-year anniversary of the grant date and then convert into shares of Common Stock, unless he has elected to defer receipt until leaving the board or a future specified year. After this award, he directly holds 92,655.011 shares of Common Stock.
Genworth Financial, Inc. reported the results of its 2026 annual stockholders meeting held on May 20, 2026. Shareholders elected all ten director nominees, with votes for individual directors ranging from 300,269,224 to 306,779,465 and broker non-votes of 30,908,201 for each nominee.
Stockholders also approved, on an advisory basis, compensation for named executive officers with 303,193,071 votes for and 10,747,307 against. They approved the 2026 Genworth Financial, Inc. Associate Stock Purchase Plan with 307,109,681 votes for, and ratified the selection of KPMG LLP as independent registered public accounting firm for 2026 with 333,181,180 votes for.
Genworth Financial Inc. reports that Donald Smith & Co., Inc. and affiliated DSCO Value Fund, L.P. beneficially own 25,486,303 shares of Common Stock, representing 6.58% of the class as of 03/31/2026. The filing lists sole voting power 24,743,136 and sole dispositive power 25,249,506.
The filing states Donald Smith & Co., Inc. acts as investment adviser and that ultimate power to direct receipt of dividends and sale proceeds rests with its institutional clients; no single client owns more than 5% of the class, per the schedule.
Genworth Financial reported Q1 2026 total revenues of $1.78 billion, roughly flat versus $1.79 billion a year earlier. Income from continuing operations was $80 million, down from $90 million, with net income available to common stockholders of $47 million versus $54 million.
Basic and diluted EPS were $0.12, compared with $0.13. Operating cash flow improved to $91 million from $34 million. Total investments were $58.5 billion, and total assets were $86.8 billion with equity of $9.84 billion as of March 31, 2026.
Under a $350 million share repurchase program, the company bought 7.7 million shares in Q1 2026 for $67 million at an average price of $8.61, and a further 2.2 million shares in April at $8.53, leaving about $175 million authorized as of April 30, 2026.
Genworth Financial reported first quarter 2026 net income of $47M, or $0.12 per diluted share, on total revenues of $1.78B. The company’s new primary performance measure, adjusted operating income excluding Closed Block, was $109M, or $0.28 per diluted share.
The Enact mortgage insurance segment generated adjusted operating income of $140M, with primary new insurance written of $12.8B and a loss ratio of 15%. Enact’s PMIERs sufficiency ratio was 162%, or $1.9B above requirements, and it increased its quarterly dividend to $0.24 per share.
The Closed Block long-term care and life businesses posted an adjusted operating loss of $32M, including a $36M pre-tax actual-versus-expected loss and GLIC consolidated RBC ratio of 289%. Holding-company cash and liquid assets were $166M, and Genworth repurchased $66M of shares in the quarter, bringing total buybacks since program inception to $856M.
Genworth Financial Inc filed a Form 13F reporting its institutional holdings as of the report period. The filing lists 2 information-table entries with a reported aggregate value of $427,736,917. The form is signed by Darren W. Woodell, Vice President and Controller, on 04-30-2026.